Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

All SEC Filings

Date Form Description PDF XBRL Pages
12/19/16 UPLOAD SEC-generated letter 2
12/02/16 S-1 General form of registration statement for all companies including face-amount certificate companies
Documents
140
11/21/16 8-K Current report filing
Documents
9
11/21/16 10-Q Quarterly report pursuant to Section 13 or 15(d) 41
11/21/16 10-Q/A Quarterly report pursuant to Section 13 or 15(d) 32
11/18/16 8-K Current report filing 3
11/15/16 NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB 3
10/21/16 8-K Current report filing
Documents
11
10/13/16 8-K Current report filing
Documents
33
10/11/16 8-K Current report filing
Documents
5
RSS